185 related articles for article (PubMed ID: 6126285)
1. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
Adam WR; Meagher EJ; Barter CE
Clin Exp Hypertens A; 1982; 4(8):1419-28. PubMed ID: 6126285
[TBL] [Abstract][Full Text] [Related]
2. Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
Dal Negro RW; Zoccatelli O; Pomari C; Trevisan F; Turco P
Int J Clin Pharmacol Res; 1986; 6(4):283-9. PubMed ID: 2875954
[TBL] [Abstract][Full Text] [Related]
3. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
[TBL] [Abstract][Full Text] [Related]
4. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
McNeil JJ; Louis WJ
Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker subtypes and risk of low birth weight in newborns.
Duan L; Ng A; Chen W; Spencer HT; Lee MS
J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1603-1609. PubMed ID: 30267456
[TBL] [Abstract][Full Text] [Related]
6. Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
Steinrauf LK; Schulz AR; Ryder KW; Brunn PW; Cook D; Judy W
Indiana Med; 1985 Jul; 78(7):600-4. PubMed ID: 2863304
[No Abstract] [Full Text] [Related]
7. [Iatrogenic dermatoses caused by beta-blocking drugs].
Alinovi A; Branchetti A; Barella PA
G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
[No Abstract] [Full Text] [Related]
8. Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma.
Jackson SH; Beevers DG
Br J Clin Pharmacol; 1983 May; 15(5):553-6. PubMed ID: 6860529
[TBL] [Abstract][Full Text] [Related]
9. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
10. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
Frishman WH; Michelson EL; Johnson BF; Poland MP
Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
[TBL] [Abstract][Full Text] [Related]
11. Alpha- and beta-receptor blocking drugs in the treatment of hypertension.
Ram CV; Kaplan NM
Curr Probl Cardiol; 1979 Jan; 3(10):1-53. PubMed ID: 40755
[TBL] [Abstract][Full Text] [Related]
12. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
[No Abstract] [Full Text] [Related]
13. Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.
Kubik MM; Coote JH
Eur J Clin Pharmacol; 1984; 26(1):1-6. PubMed ID: 6143666
[TBL] [Abstract][Full Text] [Related]
14. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
Michelson EL; Frishman WH
Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
[TBL] [Abstract][Full Text] [Related]
15. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
Pugsley DJ; Nassim M; Armstrong BK; Beilin L
Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
[TBL] [Abstract][Full Text] [Related]
17. Labetalol: an alpha- and beta-blocker.
Conner CS
Drug Intell Clin Pharm; 1983; 17(7-8):543-4. PubMed ID: 6135593
[TBL] [Abstract][Full Text] [Related]
18. Comparison of labetalol and propranolol in hypertension.
Nicholls DP; Husaini MH; Bulpitt CJ; Stephens MD; Butler AG
Br J Clin Pharmacol; 1980 Mar; 9(3):233-7. PubMed ID: 6988003
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administration.
Wunderlich J; Macha HN; Wudicke H; Huckauf H
Chest; 1980 Nov; 78(5):714-20. PubMed ID: 6107217
[TBL] [Abstract][Full Text] [Related]
20. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers.
van der Woude HJ; Zaagsma J; Postma DS; Winter TH; van Hulst M; Aalbers R
Chest; 2005 Mar; 127(3):818-24. PubMed ID: 15764762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
